Zusammenfassung
Ältere Patientinnen mit Brustkrebs werden seltener leitliniengerecht therapiert und seltener in klinische Studien eingeschlossen. Dies führt zu einer Reduktion der rezidivfreien Zeit und des Gesamtüberlebens. Es gilt, die Patientinnen zu definieren, die sich für eine leitliniengerechte Therapie eignen und den nicht geeigneten Patientinnen die bestmögliche „reduzierte“ Therapie anzubieten. Dazu müssen vernachlässigte Aspekte wie körperliche Fitness und Behinderung im Alltag, soziale Netzwerke, Lebensqualität und allgemeine Komorbiditäten verstärkt berücksichtigt werden. Hierzu kann ein angepasstes geriatrisches Assessment dienen. In diesem Artikel wird eine Übersicht über die aktuelle Datenlage bezüglich Therapiemodalitäten und -nebenwirkungen gegeben sowie eine Auswahl geriatrischer Assessments aufgezeigt.
Abstract
Standard treatment of breast cancer patients decreases with age, and older women are usually excluded from clinical trials. This results in decreased overall survival and disease-free survival. To improve treatment options for the older person, it is important to identify those who would benefit from an aggressive standard treatment and those who would not. In older women with breast cancer, physical function and disability, social support, quality of life, and overall comorbidity are important clinical parameters that, to a great extent, determine treatment success. This article gives an overview of specific treatment modalities, typical adverse events, and methods of geriatric assessment.
Literatur
Audisio RA, Bozzetti F, Gennari R et al (2004) The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 40(7):926–938
Audisio RA, Ramesh H, Longo WE et al (2005) Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 10(4):262–268
Baum M, Buzdar A, Cuzick J et al (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 98(9):1802–1810
Bouchardy C, Rapiti E, Fioretta G et al (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21(19):3580–3587
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Crivellari D, Aapro M, Leonard R et al (2007) Breast cancer in the elderly. J Clin Oncol 25(14):1882–1890
Crivellari D, Sun Z, Coates AS et al (2008) Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. J Clin Oncol 26(12):1972–1979
Doyle JJ, Neugut AI, Jacobson JS et al (2005) Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 23(34):8597–8605
Eaker S, Dickman PW, Bergkvist L, Holmberg L (2006) Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 3(3):e25
(n a) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
Eifel P, Axelson JA, Costa J et al (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93(13):979–989
Elkin EB, Hurria A, Mitra N et al (2006) Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol 24(18):2757–2764
Extermann M, Hurria A (2007) Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25(14):1824–1831
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
Freyer G, Geay J, Touzet S et al (2005) Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 16(11):1795–1800
Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351(10):963–970
Gajdos C, Tartter PI, Bleiweiss IJ et al (2001) The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192(6):698–707
Giordano SH, Duan Z, Kuo Y et al (2006) Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24(18):2750–2756
Goodwin JS, Samet JM, Hunt WC (1996) Determinants of survival in older cancer patients. J Natl Cancer Inst 88(15):1031–1038
Hancke K, Denkinger MD, Koenig J et al (n d) Standard treatment of female breast cancer patients decreases substatially for women aged 70 and older: a German clinical cohort study in progress. Ann Oncol
Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years‘ adjuvant treatment for breast cancer. Lancet 365(9453):60–62
Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971–977
Hurria A, Lichtman SM, Gardes J et al (2007) Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. J Am Geriatr Soc 55(10):1604–1608
Hurria A, Rosen C, Hudis C et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54(6):925–931
Kohn N, Kalbe E, Georg H, Kessler J (2007) Aktuelle Neurologie. Vergleich MMST und DemTect: Spezifität und Sensitivität bei primär kognitiven Störungen, (34 Suppl 2):672
Kreienberg et al (o J) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Deutsche Krebsgesellschaft e.V., W. Zuckschwerdt Verlag GmbH
Lubben J, Blozik E, Gillmann G et al (2006) Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 46(4):503–513
Maione P, Perrone F, Gallo C et al (2005) Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23(28):6865–6872
Muss HB, Berry DA, Cirrincione CT et al (2009) Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 360(20):2055–2065
Muss HB, Tu D, Ingle JN et al (2008) Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol 26(12):1956–1964
Muss HB, Woolf S, Berry D et al (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293(9):1073–1081
Nikolaus T, Pientka L (o J) Assessment bei älteren Menschen. In: Funktionelle Diagnostik, 1. Aufl.Quelle & Meyer, S. 224
Podsiadlo D, Richardson S (1991) The timed „Up & Go“: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148
Ramesh HSJ, Jain S, Audisio RA (2005) Implications of aging in surgical oncology. Cancer J 11(6)488–494
Ravdin PM, Siminoff LA, Davis GJ et al (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19(4):980–991
Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland (Hrsg) (2008) Krebs in Deutschland 2003 - 2004. Häufigkeiten und Trends (6. Aufl.) Berlin
Samain E, Schauvliège F, Deval B, Marty J (2003) Anesthesia for breast cancer surgery in the elderly. Crit Rev Oncol Hematol 46(2):115–120
Thürlimann B, Keshaviah A, Coates AS et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747–2757
Veronesi U, Marubini E, Mariani L et al (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12(7):997–1003
Vinh-Hung V, Verschraegen C (2004) Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96(2):115–121
Weeks SK, McGann PE, Michaels TK, Penninx BWJH (2003) Comparing various short-form Geriatric Depression Scales leads to the GDS-5/15. J Nurs Scholarsh 35(2):133–137
Wildiers H, Kunkler I, Biganzoli L et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8(12):1101–1115
Yancik R, Wesley MN, Ries LA et al (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885–892
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hancke, K., Denkinger, M., Kurzeder, C. et al. Mammakarzinom: die ältere Patientin. Gynäkologe 42, 675–680 (2009). https://doi.org/10.1007/s00129-009-2359-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-009-2359-1